Latest News for: novo

Edit

A cowboy-themed night for the Novo Ecijanos

The Manila Times 09 Oct 2026
I T was a lively evening of friendship, music and camaraderie as a group of Novo Ecijanos gathered for a fellowship night at the Main Lounge of the Manila Polo Club.
Edit

Novo goes on deal spree amid semaglutide patent expiries

Chemistry World 07 Oct 2026
Danish firm aims to bolster pipeline of weight-loss and metabolic disease therapies ....
Edit

Novo Nordisk A/S – Share repurchase programme (Form 6-K) (Novo Nordisk A/S)

Public Technologies 06 Oct 2026
Novo Nordisk A/S - Share repurchase programme ... Under the programme initiated 6 May 2026, Novo Nordisk will repurchase B shares for an amount up to DKK 11,200,000,010.45 in the period from 6 May 2026 to 1 February 2027 ... Novo Nordisk Investors..
Edit

Novo provides update on the denecimig Biologics License Application (BLA) in the US (Form 6-K) (Novo Nordisk A/S)

Public Technologies 05 Oct 2026
Novo provides update on the denecimig Biologics License Application (BLA) in the US • The US Food and Drug Administration (FDA) has informed Novo that the BLA review of denecimig for the treatment of haemophilia A is still ongoing ... Novo Nordisk A/S.
Edit

Novo Nordisk A/S – Share repurchase programme

Nasdaq Globe Newswire 05 Oct 2026
Bagsværd, Denmark, 5 October 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase ...
Edit

Novo Groblje Glina

Balkan Insight 05 Oct 2026
Glina’s Novo Groblje (New Cemetery) is not where the killings happened. It is where the occupying authorities put the bodies ... Joševica was spared during the first months of the occupation ... On 5 November 1991 that ended ... Most were elderly ... ....
Edit

Why Lilly and Novo are betting on amylin to power a new wave of obesity ...

CNBC 02 Oct 2026
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes ... .
Edit

Novo Holdings co-leads AnaCardio’s €62.5 million Series B financing to advance transformational novel therapy in heart failure (Novo Holdings A/S)

Public Technologies 01 Oct 2026
"This €62.5 million Series B, co-led by Novo Holdings and the Ljungström family office, fully funds GOAL-HF2, AC01's 400-patient Phase 2b trial across 12 countries, with a design agreed with the FDA and EMA.
Edit

BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter (Form 8-K) (BioCardia Inc)

Public Technologies 01 Oct 2026
). BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter. SUNNYVALE, Calif ... [Nasdaq ... The revised De Novo pre-submission for the Helix catheter incorporates the advice from FDA CDRH detailed in the minutes ... About BioCardia.
×